Skip to main content

Advertisement

SpringerLink
Log in

Lifetime costs of the top five cancers in Taiwan

  • Original Paper
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

Abstract

The purpose of this study was to determine cancer-related medical care costs for long-term cancer care costs of breast, cervical, liver, lung, and colorectal cancer. Data were sourced from Taipei Veterans General Hospital cancer registry and claim data during 1999–2002. Besides, claimed data from National Health Insurance were used to match the comparison group. To estimate lifetime cost (10 years), the whole disease process was divided into initial, continuing, and terminal three phases. The expected lifetime cost of a specific cancer patient was estimated by incorporating the average phase-specific costs with the survival rate and mortality rate. The undiscounted average lifetime costs (10 years) for lung cancer, colorectal cancer, liver cancer, cervical cancer, and breast cancer were NT$448,371 (1USD≒NTD 33), NT$584,985, NT$351,222, NT$511,563, and NT$674,282 (in 2002 NTD), respectively. The aggregate lifetime cost of cancer is useful for health policymaking and clinical decision-making.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Department of Health EY. Cancer registry annual report in Taiwan Area, 2006. Department of Health, Executive Yuan. Taipei (2009)

  2. Chen, C.J., You, S.L., Lin, L.H., Hsu, W.L., Yang, Y.W.: Cancer epidemiology and control in Taiwan: a brief review. Jpn. J. Clin. Oncol. 32(Suppl), S66–S81 (2002)

    Article  PubMed  Google Scholar 

  3. Chu, P.C., Hwang, J.S., Wang, J.D., Chang, Y.Y.: Estimation of the financial burden to the National Health Insurance for patients with major cancers in Taiwan. J. Formos. Med. Assoc. 107, 54–63 (2008)

    Article  PubMed  Google Scholar 

  4. Liu, C.N., Yang, M.C.: National health insurance expenditure for adult beneficiaries in Taiwan in their last year of life. J. Formos. Med. Assoc. 101(8), 552–559 (2002)

    PubMed  Google Scholar 

  5. White, E., Urban, N., Taylor, V.: Mammography utilization, public health impact, and cost-effectiveness in the United States. Annu. Rev. Public Health 14, 605–633 (1993)

    Article  PubMed  CAS  Google Scholar 

  6. Chen, Y.S., Wang, W.H., Chan, T., Sun, S.S., Kao, A.: A review of the cost-effectiveness of Tc-99 m sestamibi scintimammography in diagnosis of breast cancer in Taiwanese women with indeterminate mammographically dense breast. Surg. Oncol. 11(3), 151–155 (2002)

    Article  PubMed  Google Scholar 

  7. Selby, J.V., Friedman, G.D., Quesenberry Jr., C.P., Weiss, N.S.: A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N. Engl. J. Med. 326(10), 653–657 (1992)

    Article  PubMed  CAS  Google Scholar 

  8. Chen, T.H., Yen, M.F., Lai, M.S., et al.: Evaluation of a selective screening for colorectal carcinoma: the Taiwan Multicenter Cancer Screening (TAMCAS) project. Cancer 86(7), 1116–1128 (1999)

    Article  PubMed  CAS  Google Scholar 

  9. Baker, M.S., Kessler, L.G., Urban, N., Smucker, R.C.: Estimating the treatment costs of breast and lung cancer. Med. Care 29(1), 40–49 (1991)

    Article  PubMed  CAS  Google Scholar 

  10. Lang, H.C., Wu, J.C., Yen, S.H., Lan, C.F., Wu, S.L.: The lifetime cost of hepatocellular carcinoma: a claims data analysis from a medical centre in Taiwan. Appl. Health Econ. Health Policy 6(1), 55–65 (2008)

    Article  PubMed  Google Scholar 

  11. Riley, G.F., Lubitz, J.D.: Longitudinal patterns of Medicare use by cause of death. Health Care Financ. Rev. 11(2), 1–12 (1989)

    PubMed  CAS  Google Scholar 

  12. Koroukian, S.M., Beaird, H., Madigan, E., Diaz, M.: End-of-life expenditures by Ohio Medicaid beneficiaries dying of cancer. Health Care Financ. Rev. 28(2), 65–80 (2006)

    PubMed  Google Scholar 

  13. Riley, G., Lubitz, J., Prihoda, R., Rabey, E.: The use and costs of Medicare services by cause of death. Inquiry 24(3), 233–244 (1987)

    PubMed  CAS  Google Scholar 

  14. Kardamanidis, K., Lim, K., Da Cunha, C., Taylor, L.K., Jorm, L.R.: Hospital costs of older people in New South Wales in the last year of life. Med. J. Aust. 187(7), 383–386 (2007)

    PubMed  Google Scholar 

  15. de Kok, I.M., Polder, J.J., Habbema, J.D., et al.: The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening. Br. J. Cancer 100(8), 1240–1244 (2009)

    Article  PubMed  Google Scholar 

  16. Brown, M.L., Riley, G.F., Schussler, N., Etzioni, R.: Estimating health care costs related to cancer treatment from SEER-Medicare data. Med. Care 40(8 Suppl), IV-104–IV-117 (2002)

    Google Scholar 

  17. Warren, J.L., Brown, M.L., Fay, M.P., Schussler, N., Potosky, A.L., Riley, G.F.: Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings. J. Clin. Oncol. 20(1), 307–316 (2002)

    Article  PubMed  Google Scholar 

  18. Kutikova, L., Bowman, L., Chang, S., Long, S.R., Obasaju, C., Crown, W.H.: The economic burden of lung cancer and the associated costs of treatment failure in the United States. Lung Cancer 50(2), 143–154 (2005)

    Article  PubMed  Google Scholar 

  19. Dedes, K.J., Szucs, T.D., Bodis, S., et al.: Management and costs of treating lung cancer patients in a university hospital. Pharmacoeconomics 22(7), 435–444 (2004)

    Article  PubMed  Google Scholar 

  20. Riley, G.F., Warren, J.L., Potosky, A.L., Klabunde, C.N., Harlan, L.C., Osswald, M.B.: Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans. Med. Care 46(10), 1108–1115 (2008)

    Article  PubMed  Google Scholar 

  21. Will, B.P., Berthelot, J.M., Le Petit, C., Tomiak, E.M., Verma, S., Evans, W.K.: Estimates of the lifetime costs of breast cancer treatment in Canada. Eur. J. Cancer 36(6), 724–735 (2000)

    Article  PubMed  CAS  Google Scholar 

  22. Riley, G.F., Potosky, A.L., Lubitz, J.D., Kessler, L.G.: Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med. Care 33(8), 828–841 (1995)

    Article  PubMed  CAS  Google Scholar 

  23. Riley, G.F., Potosky, A.L., Klabunde, C.N., Warren, J.L., Ballard-Barbash, R.: Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. JAMA 281(8), 720–726 (1999)

    Article  PubMed  CAS  Google Scholar 

  24. Riley, G.F., Potosky, A.L., Lubitz, J.D., Brown, M.L.: Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am. J. Public Health 84(10), 1598–1604 (1994)

    Article  PubMed  CAS  Google Scholar 

  25. Taplin, S.H., Barlow, W., Urban, N., et al.: Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J. Natl Cancer Inst. 87(6), 417–426 (1995)

    Article  PubMed  CAS  Google Scholar 

  26. Etzioni, R., Urban, N., Baker, M.: Estimating the costs attributable to a disease with application to ovarian cancer. J. Clin. Epidemiol. 49(1), 95–103 (1996)

    Article  PubMed  CAS  Google Scholar 

  27. Potosky, A.L., Riley, G.F., Lubitz, J.D., Mentnech, R.M., Kessler, L.G.: Potential for cancer related health services research using a linked Medicare-tumor registry database. Med. Care 31(8), 732–748 (1993)

    Article  PubMed  CAS  Google Scholar 

  28. Ramsey, S.D., Berry, K., Etzioni, R.: Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer. Am. J. Gastroenterol. 97(2), 440–445 (2002)

    Article  PubMed  Google Scholar 

  29. Brown, M.L., Riley, G.F., Potosky, A.L., Etzioni, R.D.: Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. Med. Care 37(12), 1249–1259 (1999)

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was funded by Taiwan National Health Research Institute (NHRI-EX94-9007PC). I would like to especially thank Jaw-Ching Wu for the SAS programming.

Author information

Authors and Affiliations

  1. Institute of Hospital and Health Care Administration, National Yang-Ming University, No.155, Sec. 2, Li-Nong St., Taipei, 112, Taiwan

    Hui-Chu Lang

  2. Research Center for Health data, National Cheng Kung University, Tainan, Taiwan

    Shi-Liang Wu

Authors
  1. Hui-Chu Lang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shi-Liang Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hui-Chu Lang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lang, HC., Wu, SL. Lifetime costs of the top five cancers in Taiwan. Eur J Health Econ 13, 347–353 (2012). https://doi.org/10.1007/s10198-011-0307-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-011-0307-1

Keywords

JEL Classification

Search

Navigation